Want to join the conversation?
$EGRX said FDA has approved Docetaxel Injection, Non-Alcohol Formula. $EGRX entered into exclusive licensing agreement with Teikoku Pharma USA in Oct. to market, sell and distribute Docetaxel Injection in the U.S. $EGRX estimates that annual sales of generic docetaxel are about $75MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?